J Gen Virol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 78 (1997), 1907-1911
© 1997 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saifuddin, M.
Right arrow Articles by Spear, G. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saifuddin, M.
Right arrow Articles by Spear, G. T.
Agricola
Right arrow Articles by Saifuddin, M.
Right arrow Articles by Spear, G. T.

Journal of General Virology, Vol 78, 1907-1911, Copyright © 1997 by Society for General Microbiology


ARTICLES

Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction

M Saifuddin, T Hedayati, JP Atkinson, MH Holguin, CJ Parker and GT Spear
Department of Immunology/Microbiology, Rush University, Chicago, IL 60612, USA. msaifudd@rush.edu

Human immunodeficiency virus type 1 (HIV-1) can be either resistant or sensitive to complement-mediated destruction depending on the host cells. Incorporation of different levels of host cell CD46, CD55 and CD59 may account for this differential sensitivity to complement. However, it has not been determined whether CD46, CD55 and CD59 can all be incorporated at levels which protect virions. To determine whether each of these proteins can protect HIV-1, virions were derived from CHO cells expressing either human CD46, CD55 or CD59. Virions were shown to incorporate both glycosyl phosphatidylinositol (GPI)-anchored CD55 and CD59 as well as transmembrane CD46. Importantly, all three virus preparations were significantly more resistant to complement lysis than control virus. This study demonstrates that HIV-1 incorporates both transmembrane and GPI-anchored complement control proteins from host cells and that both types of protein increase complement resistance of virus.


This article has been cited by other articles:


Home page
J. Virol.Home page
J. B. Johnson, K. Grant, and G. D. Parks
The Paramyxoviruses Simian Virus 5 and Mumps Virus Recruit Host Cell CD46 To Evade Complement-Mediated Neutralization
J. Virol., August 1, 2009; 83(15): 7602 - 7611.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. M. Girgis, B. C. DeHaven, X. Fan, K. M. Viner, M. Shamim, and S. N. Isaacs
Cell Surface Expression of the Vaccinia Virus Complement Control Protein Is Mediated by Interaction with the Viral A56 Protein and Protects Infected Cells from Complement Attack
J. Virol., May 1, 2008; 82(9): 4205 - 4214.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Bouhlal, N. Chomont, M. Requena, N. Nasreddine, H. Saidi, J. Legoff, M. D. Kazatchkine, L. Belec, and H. Hocini
Opsonization of HIV with Complement Enhances Infection of Dendritic Cells and Viral Transfer to CD4 T Cells in a CR3 and DC-SIGN-Dependent Manner
J. Immunol., January 15, 2007; 178(2): 1086 - 1095.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
O. B. Spiller, L. Mark, C. E. Blue, D. G. Proctor, J. A. Aitken, A. M. Blom, and D. J. Blackbourn
Dissecting the Regions of Virion-Associated Kaposi's Sarcoma-Associated Herpesvirus Complement Control Protein Required for Complement Regulation and Cell Binding.
J. Virol., April 1, 2006; 80(8): 4068 - 4078.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
K. Kolegraff, P. Bostik, and A. A. Ansari
Characterization and role of lentivirus-associated host proteins.
Experimental Biology and Medicine, March 1, 2006; 231(3): 252 - 263.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
P. Goluszko and B. Nowicki
Membrane Cholesterol: a Crucial Molecule Affecting Interactions of Microbial Pathogens with Mammalian Cells
Infect. Immun., December 1, 2005; 73(12): 7791 - 7796.
[Full Text] [PDF]


Home page
BloodHome page
S. J. D. Neil, A. McKnight, K. Gustafsson, and R. A. Weiss
HIV-1 incorporates ABO histo-blood group antigens that sensitize virions to complement-mediated inactivation
Blood, June 15, 2005; 105(12): 4693 - 4699.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
R. Cantin, S. Methot, and M. J. Tremblay
Plunder and Stowaways: Incorporation of Cellular Proteins by Enveloped Viruses
J. Virol., June 1, 2005; 79(11): 6577 - 6587.
[Full Text] [PDF]


Home page
J. Virol.Home page
M. M. I. Aasa-Chapman, S. Holuigue, K. Aubin, M. Wong, N. A. Jones, D. Cornforth, P. Pellegrino, P. Newton, I. Williams, P. Borrow, et al.
Detection of Antibody-Dependent Complement-Mediated Inactivation of both Autologous and Heterologous Virus in Primary Human Immunodeficiency Virus Type 1 Infection
J. Virol., March 1, 2005; 79(5): 2823 - 2830.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Magre, Y. Takeuchi, G. Langford, A. Richards, C. Patience, and R. Weiss
Reduced Sensitivity to Human Serum Inactivation of Enveloped Viruses Produced by Pig Cells Transgenic for Human CD55 or Deficient for the Galactosyl-{alpha}(1-3) Galactosyl Epitope
J. Virol., June 1, 2004; 78(11): 5812 - 5819.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. G. Nguyen, A. Booth, S. J. Gould, and J. E. K. Hildreth
Evidence That HIV Budding in Primary Macrophages Occurs through the Exosome Release Pathway
J. Biol. Chem., December 26, 2003; 278(52): 52347 - 52354.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. de Gassart, C. Geminard, B. Fevrier, G. Raposo, and M. Vidal
Lipid raft-associated protein sorting in exosomes
Blood, December 15, 2003; 102(13): 4336 - 4344.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
G. R. Van de Walle, H. W. Favoreel, H. J. Nauwynck, and M. B. Pensaert
Antibody-induced internalization of viral glycoproteins and gE-gI Fc receptor activity protect pseudorabies virus-infected monocytes from efficient complement-mediated lysis
J. Gen. Virol., April 1, 2003; 84(4): 939 - 947.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Pausa, V. Pellis, M. Cinco, P. G. Giulianini, G. Presani, S. Perticarari, R. Murgia, and F. Tedesco
Serum-Resistant Strains of Borrelia burgdorferi Evade Complement-Mediated Killing by Expressing a CD59-Like Complement Inhibitory Molecule
J. Immunol., March 15, 2003; 170(6): 3214 - 3222.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
H. W. Favoreel, G. R. Van de Walle, H. J. Nauwynck, and M. B. Pensaert
Virus complement evasion strategies
J. Gen. Virol., January 1, 2003; 84(1): 1 - 15.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Bavari, C. M. Bosio, E. Wiegand, G. Ruthel, A. B. Will, T. W. Geisbert, M. Hevey, C. Schmaljohn, A. Schmaljohn, and M. J. Aman
Lipid Raft Microdomains: A Gateway for Compartmentalized Trafficking of Ebola and Marburg Viruses
J. Exp. Med., March 4, 2002; 195(5): 593 - 602.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
D. M. Takefman, G. T. Spear, M. Saifuddin, and C. A. Wilson
Human CD59 Incorporation into Porcine Endogenous Retrovirus Particles: Implications for the Use of Transgenic Pigs for Xenotransplantation
J. Virol., February 15, 2002; 76(4): 1999 - 2002.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
M. T. Esser, D. R. Graham, L. V. Coren, C. M. Trubey, J. W. Bess Jr., L. O. Arthur, D. E. Ott, and J. D. Lifson
Differential Incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and Major Histocompatibility Complex Class I and II Molecules into Human Immunodeficiency Virus Type 1 Virions and Microvesicles: Implications for Viral Pathogenesis and Immune Regulation
J. Virol., July 1, 2001; 75(13): 6173 - 6182.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. M. Friedman, L. Wang, M. K. Pangburn, J. D. Lambris, and J. Lubinski
Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1
J. Immunol., October 15, 2000; 165(8): 4528 - 4536.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
M. Saifuddin, M. L. Hart, H. Gewurz, Y. Zhang, and G. T. Spear
Interaction of mannose-binding lectin with primary isolates of human immunodeficiency virus type 1
J. Gen. Virol., April 1, 2000; 81(4): 949 - 955.
[Abstract] [Full Text]


Home page
J. Virol.Home page
D. H. Nguyen and J. E. K. Hildreth
Evidence for Budding of Human Immunodeficiency Virus Type 1 Selectively from Glycolipid-Enriched Membrane Lipid Rafts
J. Virol., April 1, 2000; 74(7): 3264 - 3272.
[Abstract] [Full Text]


Home page
J. Virol.Home page
S. D. Lawn, B. D. Roberts, G. E. Griffin, T. M. Folks, and S. T. Butera
Cellular Compartments of Human Immunodeficiency Virus Type 1 Replication In Vivo: Determination by Presence of Virion-Associated Host Proteins and Impact of Opportunistic Infection
J. Virol., January 1, 2000; 74(1): 139 - 145.
[Abstract] [Full Text]


Home page
J. Virol.Home page
N. J. DePolo, C. E. Harkleroad, M. Bodner, A. T. Watt, C. G. Anderson, J. S. Greengard, K. K. Murthy, T. W. Dubensky Jr., and D. J. Jolly
The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent
J. Virol., August 1, 1999; 73(8): 6708 - 6714.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1997 by the Society for General Microbiology.